KR100191943B1 - 인터루킨-1 저해제 - Google Patents

인터루킨-1 저해제 Download PDF

Info

Publication number
KR100191943B1
KR100191943B1 KR1019950703767A KR19950703767A KR100191943B1 KR 100191943 B1 KR100191943 B1 KR 100191943B1 KR 1019950703767 A KR1019950703767 A KR 1019950703767A KR 19950703767 A KR19950703767 A KR 19950703767A KR 100191943 B1 KR100191943 B1 KR 100191943B1
Authority
KR
South Korea
Prior art keywords
interleukin
disease
diseases
acid
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019950703767A
Other languages
English (en)
Korean (ko)
Other versions
KR960700720A (ko
Inventor
마사카즈 아다치
히사시 타마오카
유키히사 오노
Original Assignee
오스카 아키히코
오스카 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오스카 아키히코, 오스카 세이야꾸 가부시끼가이샤 filed Critical 오스카 아키히코
Publication of KR960700720A publication Critical patent/KR960700720A/ko
Application granted granted Critical
Publication of KR100191943B1 publication Critical patent/KR100191943B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019950703767A 1993-03-10 1994-02-22 인터루킨-1 저해제 Expired - Lifetime KR100191943B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4850193 1993-03-10
JP93-48501 1993-03-10
PCT/JP1994/000266 WO1994020105A1 (en) 1993-03-10 1994-02-22 Interleukin-1 inhibitor

Publications (2)

Publication Number Publication Date
KR960700720A KR960700720A (ko) 1996-02-24
KR100191943B1 true KR100191943B1 (ko) 1999-06-15

Family

ID=12805138

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950703767A Expired - Lifetime KR100191943B1 (ko) 1993-03-10 1994-02-22 인터루킨-1 저해제

Country Status (11)

Country Link
EP (1) EP0688218B1 (enExample)
KR (1) KR100191943B1 (enExample)
CN (1) CN1088586C (enExample)
AT (1) ATE186642T1 (enExample)
AU (1) AU676267B2 (enExample)
DE (1) DE69421694T2 (enExample)
DK (1) DK0688218T3 (enExample)
ES (1) ES2140531T3 (enExample)
GR (1) GR3032492T3 (enExample)
TW (1) TW244336B (enExample)
WO (1) WO1994020105A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750224B1 (en) 1999-05-07 2004-06-15 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
US6514986B2 (en) 2000-11-22 2003-02-04 Wockhardt Limited Chiral fluoroquinolone arginine salt forms
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
TWI287987B (en) * 2000-08-14 2007-10-11 Senju Pharma Co Cytokine inhibitor
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6664267B1 (en) 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
ATE366734T1 (de) 2003-09-04 2007-08-15 Wockhardt Ltd Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
JPS5995220A (ja) * 1982-11-22 1984-06-01 Ajinomoto Co Inc 免疫療法剤
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4894374A (en) * 1988-08-17 1990-01-16 American Home Products Corporation Substituted 1,2-dihydro-4h-3,1-benzoxazin-4-one derivatives inhibitors of interleukin 1
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions

Also Published As

Publication number Publication date
ATE186642T1 (de) 1999-12-15
ES2140531T3 (es) 2000-03-01
AU676267B2 (en) 1997-03-06
DE69421694T2 (de) 2000-05-25
CN1118991A (zh) 1996-03-20
AU6046194A (en) 1994-09-26
DK0688218T3 (da) 2000-03-13
GR3032492T3 (en) 2000-05-31
EP0688218B1 (en) 1999-11-17
KR960700720A (ko) 1996-02-24
DE69421694D1 (en) 1999-12-23
TW244336B (enExample) 1995-04-01
WO1994020105A1 (en) 1994-09-15
CN1088586C (zh) 2002-08-07
EP0688218A1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
KR0148589B1 (ko) 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
KR100424124B1 (ko) 동맥경화및황색종의치료
EP0753301B1 (en) Combination of a benzimidazole having angiotensin-II antagonistic activity with a diuretic
US20090191265A1 (en) Capsule Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients
JP2006512334A (ja) Ｄｐｐ−ｉｖ阻害剤とｐｐａｒ−アルファ化合物の組み合わせ
HUE029853T2 (en) Pharmaceutical formulations comprising 1-(beta-d-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of sglt
KR100191943B1 (ko) 인터루킨-1 저해제
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
KR20220060488A (ko) 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정성 입자의 제조방법 및 이를 포함하는 약학적 조성물
JP2009514856A (ja) 医薬品ガリウム組成物及び方法
JP2811331B2 (ja) 骨形成促進剤
KR0133555B1 (ko) 5-플루오로우라실계 화합물에 기인한 염증의 발생을 억제할 수 있는 비-주사제 형태의 항암조성물
CZ282294B6 (cs) Inhibitor tvorby zánětlivého cytokinu obsahující polyprenylové deriváty, činidlo pro profylaxi a terapii zánětlivých střevních onemocnění a použití polyprenylových derivátů
EP1714648A1 (en) Combination drug
KR0185226B1 (ko) 이식 조직의 거부반응 억제제 및 il-1 생산 억제제
KR20130120635A (ko) 정족수 감지 억제 활성 및 항균 활성을 갖는 항균용 조성물
JPWO1994020107A1 (ja) 移植組織の拒絶反応抑制剤
JP3254712B2 (ja) 医薬組成物
CN106928212B (zh) 一种用于治疗阑尾炎的药物及其制备方法和应用
JP2636265B2 (ja) 脳循環改善剤
JPH03112928A (ja) 吸収性が改善された製剤組成物
HUT71475A (en) Pharmaceutical compositions for increasing macrophage function containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
KR20240040407A (ko) 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물
JPS61172820A (ja) カルシウム拮抗剤
JPH0352855A (ja) アクリル酸塩、それらの製造方法、それらを含む薬剤組成物および医学におけるそれらの用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19950906

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960212

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980821

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19981126

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990127

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990128

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020116

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20030123

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20040120

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20050121

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20060126

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20070125

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20080122

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20090123

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20100125

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20101223

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20120105

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20130111

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20130111

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20140107

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20140107

Start annual number: 16

End annual number: 16

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20140822

Termination category: Expiration of duration